BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 19805293)

  • 1. CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53.
    Shi D; Pop MS; Kulikov R; Love IM; Kung AL; Grossman SR
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16275-80. PubMed ID: 19805293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation.
    Lee CW; Ferreon JC; Ferreon AC; Arai M; Wright PE
    Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19290-5. PubMed ID: 20962272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pro-apoptotic function of iASPP by stabilizing p300 and CBP through inhibition of BRMS1 E3 ubiquitin ligase activity.
    Kramer D; Schön M; Bayerlová M; Bleckmann A; Schön MP; Zörnig M; Dobbelstein M
    Cell Death Dis; 2015 Feb; 6(2):e1634. PubMed ID: 25675294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The APC/C and CBP/p300 cooperate to regulate transcription and cell-cycle progression.
    Turnell AS; Stewart GS; Grand RJ; Rookes SM; Martin A; Yamano H; Elledge SJ; Gallimore PH
    Nature; 2005 Dec; 438(7068):690-5. PubMed ID: 16319895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double null cells reveal that CBP and p300 are dispensable for p53 targets p21 and Mdm2 but variably required for target genes of other signaling pathways.
    Kasper LH; Thomas MC; Zambetti GP; Brindle PK
    Cell Cycle; 2011 Jan; 10(2):212-21. PubMed ID: 21220944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.
    Ferreon JC; Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6591-6. PubMed ID: 19357310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of p300/CREB binding protein coactivators by simian virus 40 is mediated through p53.
    Borger DR; DeCaprio JA
    J Virol; 2006 May; 80(9):4292-303. PubMed ID: 16611888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential contribution of p300 and CBP to regulatory element acetylation in mESCs.
    Martire S; Nguyen J; Sundaresan A; Banaszynski LA
    BMC Mol Cell Biol; 2020 Jul; 21(1):55. PubMed ID: 32690000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyubiquitination of p53 by a ubiquitin ligase activity of p300.
    Grossman SR; Deato ME; Brignone C; Chan HM; Kung AL; Tagami H; Nakatani Y; Livingston DM
    Science; 2003 Apr; 300(5617):342-4. PubMed ID: 12690203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the interactions of adenoviral E1A proteins with the p160 nuclear receptor coactivator binding domain of CBP.
    Haberz P; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Protein Sci; 2016 Dec; 25(12):2256-2267. PubMed ID: 27699893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The WTX tumor suppressor enhances p53 acetylation by CBP/p300.
    Kim WJ; Rivera MN; Coffman EJ; Haber DA
    Mol Cell; 2012 Mar; 45(5):587-97. PubMed ID: 22285752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRMS1 suppresses lung cancer metastases through an E3 ligase function on histone acetyltransferase p300.
    Liu Y; Mayo MW; Nagji AS; Hall EH; Shock LS; Xiao A; Stelow EB; Jones DR
    Cancer Res; 2013 Feb; 73(4):1308-17. PubMed ID: 23269275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of p53 degradation by Mdm2 acetylation.
    Wang X; Taplick J; Geva N; Oren M
    FEBS Lett; 2004 Mar; 561(1-3):195-201. PubMed ID: 15013777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding and modulation of p53 by p300/CBP coactivators.
    Lill NL; Grossman SR; Ginsberg D; DeCaprio J; Livingston DM
    Nature; 1997 Jun; 387(6635):823-7. PubMed ID: 9194565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300.
    Dyson HJ; Wright PE
    J Biol Chem; 2016 Mar; 291(13):6714-22. PubMed ID: 26851278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells.
    Naidu SR; Love IM; Imbalzano AN; Grossman SR; Androphy EJ
    Oncogene; 2009 Jul; 28(27):2492-501. PubMed ID: 19448667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles for the coactivators CBP and p300 and the APC/C E3 ubiquitin ligase in E1A-dependent cell transformation.
    Turnell AS; Mymryk JS
    Br J Cancer; 2006 Sep; 95(5):555-60. PubMed ID: 16880778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2.
    Matt T; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochem J; 2004 Aug; 381(Pt 3):685-91. PubMed ID: 15154850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB and enhancer-binding CREB protein scaffolded by CREB-binding protein (CBP)/p300 proteins regulate CD59 protein expression to protect cells from complement attack.
    Du Y; Teng X; Wang N; Zhang X; Chen J; Ding P; Qiao Q; Wang Q; Zhang L; Yang C; Yang Z; Chu Y; Du X; Zhou X; Hu W
    J Biol Chem; 2014 Jan; 289(5):2711-24. PubMed ID: 24338025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIAH-mediated ubiquitination and degradation of acetyl-transferases regulate the p53 response and protein acetylation.
    Grishina I; Debus K; García-Limones C; Schneider C; Shresta A; García C; Calzado MA; Schmitz ML
    Biochim Biophys Acta; 2012 Dec; 1823(12):2287-96. PubMed ID: 23044042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.